INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,475 Cr | ₹2,137 Cr | ₹1,284 Cr | ₹559 Cr | ₹562 Cr |
What is the latest Total Liabilities ratio of INDEGENE ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,475 Cr |
Mar2023 | ₹2,137 Cr |
Mar2022 | ₹1,284 Cr |
Mar2021 | ₹559 Cr |
Mar2020 | ₹562 Cr |
How is Total Liabilities of INDEGENE Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,475 Cr | 15.82 | |
Mar2023 | ₹2,137 Cr | 66.38 | |
Mar2022 | ₹1,284 Cr | 129.63 | |
Mar2021 | ₹559 Cr | -0.41 | |
Mar2020 | ₹562 Cr | - |
Compare Total Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,346.4 Cr | -3.8% | 5.3% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | -3.8% |
5.3% |
|
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses